Delivery Order SPE2DB22D3011-SPE2DB25FQ0MK
Award Date
4/22/25
Potential Completion Date
4/23/25
Potential Value
$5.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The contract has a ceiling value of $2,246.50 and a completion date of May 29, 2025. The contract is not set aside for any particular small business category. AmerisourceBergen Drug Corp is the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a diabetes medication, with a ceiling value of $4,723.08 and a period of performance through May 5, 2025. The contract is not set aside and was awarded on May 2, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML, a medication used in the treatment of diabetes. The award has a ceiling value of $1,920.93 and a period of performance through May 19, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a diabetes medication. The contract has a ceiling value of $5,116.92 and a period of performance ending on May 19, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp is the prime contractor and holds a significant Indefinite Delivery Contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,274.39, is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a medication used in the treatment of diabetes. The contract has an ultimate completion date of February 24, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there are no set-aside requirements for this...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The contract is a firm fixed-price delivery order with a ceiling value of $7,076.16 and a performance period through May 5, 2025. AmerisourceBergen Drug Corp is the prime contractor, and the contract is not set aside. This delivery order is part of a larger Indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,088.36, is for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a medication used for the treatment of diabetes. The contract has an ultimate completion date of April 24, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The contract has a ceiling value of $10,883.60 and a period of performance through April 21, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The contract has a ceiling value of $3,498.95 and a completion date of May 20, 2025. It is a firm-fixed-price contract, indicating the price is predetermined. The contract is not designated as a set-aside, meaning it was open to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a diabetes treatment medication. The contract has a firm fixed price, with a ceiling value of $37,764.29, and a period of performance through May 28, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...